Literature DB >> 2231298

Implications of an alternative approach to dose-response trials.

L B Sheiner1.   

Abstract

Mesh：

Year:  1990        PMID： 2231298

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN： 0894-9255


× No keyword cloud information.
  4 in total

Review 1.  Non-linear mixed effects modeling - from methodology and software development to driving implementation in drug development science.

Authors:  Goonaseelan Colin Pillai; France Mentré; Jean-Louis Steimer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-11-07       Impact factor: 2.745

2.  Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee.

Authors:  S Percy Ivy; Lillian L Siu; Elizabeth Garrett-Mayer; Larry Rubinstein
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

3.  Clinical pharmacokinetics of zidovudine: inter and intraindividual variability and relationship to long term efficacy and toxicity.

Authors:  F Mentré; S Escolano; B Diquet; J L Golmard; A Mallet
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Kinetic mechanisms by which nickel alters the calcium (Ca2+) transport in intact rat liver.

Authors:  Karina Sayuri Utsunomiya; Lucas Jonatas da Silva; Juliana Iwamoto; Rodrigo Polimeni Constantin; Eduardo Hideo Gilglioni; Jorgete Constantin; Adelar Bracht; Ronald Petrus Johannes Oude Elferink; Emy Luiza Ishii-Iwamoto
Journal:  J Biol Inorg Chem       Date:  2021-07-24       Impact factor: 3.358
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.